{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:52:00Z","timestamp":1788306720208,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a rare and often fatal syndrome of abnormal T-cell activation and cytokine production, which can be familial or secondary in nature. Although HLH can occur concomitantly with lymphomas, the development of HLH alongside Hodgkin lymphoma in children is unusual. Here we report the diagnostic evaluation and clinical course of 2 pediatric cases of HLH secondary to lymphocyte-depleted classic Hodgkin lymphoma. These cases highlight the need to be vigilant for this rare presentation and the difficulties in managing these patients.<\/jats:p>","DOI":"10.1097\/mph.0000000000001398","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T01:07:53Z","timestamp":1546564073000},"page":"e341-e345","source":"Crossref","is-referenced-by-count":3,"title":["Hemophagocytic Lymphohistiocytosis Associated With 2 Cases of Pediatric Lymphocyte-depleted Classic Hodgkin Lymphoma"],"prefix":"10.1097","volume":"41","author":[{"given":"Fathima Z.","family":"Cader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Colmenero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Mussai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"e44649","DOI":"10.1371\/journal.pone.0044649","article-title":"Familial hemophagocytic lymphohistiocytosis may present during adulthood clinical and genetic features of a small series","volume":"7","author":"Sieni","year":"2012","journal-title":"PLoS One"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.2008.07315.x","article-title":"Characterization of PRF1, STX11, and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis","volume":"143","author":"Horne","year":"2008","journal-title":"Br J Haematol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/pbc.22499","article-title":"STX11 mutations and clinical phenotypes of familial hemophagocytic lymphohistiocytosis in North America","volume":"55","author":"Marsh","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","article-title":"Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)","volume":"119","author":"Pagel","year":"2012","journal-title":"Blood"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jmg.2007.052670","article-title":"Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations","volume":"45","author":"Trizzino","year":"2008","journal-title":"J Med Genet"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/653424","article-title":"Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells","volume":"51","author":"Fox","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.prp.2012.11.003","article-title":"Classical Hodgkin lymphoma, lymphocyte depleted type clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma","volume":"209","author":"Karube","year":"2013","journal-title":"Pathol Res Pract"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00277-002-0572-2","article-title":"Hemophagocytic syndrome as the primary clinical symptom of Hodgkin\u2019s disease","volume":"82","author":"Kojima","year":"2003","journal-title":"Ann Hematol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.0954-6820.2003.01249.x","article-title":"Hodgkin\u2019s lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome","volume":"255","author":"Hasselblom","year":"2004","journal-title":"J Intern Med"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/590152","article-title":"Hodgkin lymphoma-associated hemophagocytic syndrome a disorder strongly correlated with Epstein-Barr virus","volume":"47","author":"Menard","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.2169\/internalmedicine.51.8275","article-title":"Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation a case report and review of the literature","volume":"51","author":"Hagihara","year":"2012","journal-title":"Intern Med"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1200\/JCO.2011.36.4703","article-title":"Lymphocyte-depleted classical Hodgkin\u2019s lymphoma a comprehensive analysis from the German Hodgkin study group","volume":"29","author":"Klimm","year":"2011","journal-title":"J Clin Oncol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2011.05.029","article-title":"Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone\u2014the results of the United Kingdom HD3 national cohort trial","volume":"48","author":"Shankar","year":"2012","journal-title":"Eur J Cancer"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004 Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20230918","first-page":"207","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases a multicenter study from Turkey","volume":"51","author":"Celkan","year":"2009","journal-title":"Turk J Pediatr"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.13462","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents","volume":"170","author":"Lehmberg","year":"2015","journal-title":"Br J Haematol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00277-018-3254-4","article-title":"Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years","volume":"97","author":"Strenger","year":"2018","journal-title":"Ann Hematol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","article-title":"Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy","volume":"17","author":"Czuczman","year":"1999","journal-title":"J Clin Oncol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.2001.19.2.389","article-title":"Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin\u2019s lymphoma","volume":"19","author":"Vose","year":"2001","journal-title":"J Clin Oncol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian","year":"2013","journal-title":"Br J Haematol"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2012-01-402792","article-title":"Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma","volume":"119","author":"Kasamon","year":"2012","journal-title":"Blood"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2012-01-405456","article-title":"Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma","volume":"119","author":"Younes","year":"2012","journal-title":"Blood"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/10428190701713630","article-title":"Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome comparison of T-cell lymphoma with and without hemophagocytic syndrome","volume":"49","author":"Tong","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mpo.1294","article-title":"Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis","volume":"38","author":"Tomaske","year":"2002","journal-title":"Med Pediatr Oncol"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V74.8.2624.2624","article-title":"Immunophenotypes of Reed-Sternberg cells a study of 19 cases of Hodgkin\u2019s disease in plastic-embedded sections","volume":"74","author":"Casey","year":"1989","journal-title":"Blood"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2326-6066.CIR-17-0325","article-title":"Complex immune evasion strategies in classical Hodgkin lymphoma","volume":"5","author":"Wein","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.leu.2401626","article-title":"Treatment of refractory Hodgkin\u2019s lymphoma patients with an anti-CD25 ricin A-chain immunotoxin","volume":"14","author":"Schnell","year":"2000","journal-title":"Leukemia"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1073\/pnas.1516107112","article-title":"90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin\u2019s lymphoma","volume":"112","author":"Janik","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-20230918","first-page":"38","article-title":"Daclizumab withdrawn from the market worldwide","volume":"56","year":"2018","journal-title":"Drug Ther Bull"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V99.10.3554","article-title":"Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine results of a large international study","volume":"99","author":"Keating","year":"2002","journal-title":"Blood"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1542\/peds.2006-1534","article-title":"Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease: a mimicker of sepsis in the pediatric intensive care unit","volume":"119","author":"Mischler","year":"2007","journal-title":"Pediatrics"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201907000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T20:09:09Z","timestamp":1720901349000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201907000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001398","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}